Details for New Drug Application (NDA): 207807
✉ Email this page to a colleague
The generic ingredient in AMLODIPINE AND OLMESARTAN MEDOXOMIL is amlodipine besylate; olmesartan medoxomil. There are fifty drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; olmesartan medoxomil profile page.
Summary for 207807
| Tradename: | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Applicant: | Glenmark Pharms Ltd |
| Ingredient: | amlodipine besylate; olmesartan medoxomil |
| Patents: | 0 |
Suppliers and Packaging for NDA: 207807
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 207807 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-566 | 68462-566-14 | 10 BLISTER PACK in 1 CARTON (68462-566-14) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| AMLODIPINE AND OLMESARTAN MEDOXOMIL | amlodipine besylate; olmesartan medoxomil | TABLET;ORAL | 207807 | ANDA | Glenmark Pharmaceuticals Inc., USA | 68462-566 | 68462-566-30 | 30 TABLET, FILM COATED in 1 BOTTLE (68462-566-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;20MG | ||||
| Approval Date: | Jul 5, 2017 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;40MG | ||||
| Approval Date: | Jul 5, 2017 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE;20MG | ||||
| Approval Date: | Jul 5, 2017 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
